In November 2016, just after the election, President-elect Donald Trump announced Jeff Sessions as his pick for attorney general. His confirmation was still a couple of months away, but the Republican senator from Alabama went quickly to work helping to shape the Justice Department he would soon inherit.
For the last year, Foster — empowered by his boss, Sen. Charles Grassley, R-Iowa, the committee’s chairman — has been the behind-the-scenes architect of an assault on the FBI, and most centrally its role in special counsel Robert Mueller’s investigation of possible collusion between the Trump campaign and Russia, according to interviews with current and former congressional aides, federal law enforcement officials and others.
A bill was introduced following reports by ProPublica and The New York Times that disclosed the industry ties of Trump officials tasked with loosening rules covering the workplace, consumer protection and the environment.
Even before the demonstration in Virginia began last weekend, the police there knew they weren’t going to be able to handle what was coming. Charlottesville police officers, including Sgt. Jake Via of the investigations bureau, had been contacting organizers and scanning social media to figure out how many demonstrators were headed their way and whether they would be armed.
Price invested about $10,000 in 2015 and another $50,000 to $100,000 in the company last summer, records show. He appears to have sold all those shares on two days in February, reaping between $265,000 and $550,000, according to forms he filed last month with the federal Office of Government Ethics.
On the same day the stockbroker for then-Georgia Congressman Tom Price bought him up to $90,000 of stock in six pharmaceutical companies last year, Price arranged to call a top U.S. health official, seeking to scuttle a controversial rule that could have hurt the firms’ profits and driven down their share prices, records obtained by ProPublica show.
Tom Price, head of the Department of Health and Human Services, came under scrutiny during his confirmation hearings for investments he made while serving in Congress. The Georgia lawmaker traded hundreds of thousands of dollars worth of shares in health-related companies, even as he voted on and sponsored legislation affecting the industry.
After the election, an influential advocacy group met to discuss how to leverage the extraordinary shift of power to Republicans in the rest of the country. Group members said they would push bills to reduce corporate taxes, weaken unions, privatize schooling and influence the ideological debate on college campuses.